{"id":"https://openalex.org/W2037469650","doi":"https://doi.org/10.1097/00001813-199601000-00009","title":"Tissue distribution, metabolism and excretion of paclitaxel in mice","display_name":"Tissue distribution, metabolism and excretion of paclitaxel in mice","alternate_titles":[],"publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2037469650","doi":"https://doi.org/10.1097/00001813-199601000-00009","mag":"2037469650","pmid":"https://pubmed.ncbi.nlm.nih.gov/8742102"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-199601000-00009","doi":"https://doi.org/10.1097/00001813-199601000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199601000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2037469650"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":["Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Amsterdam","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034151807","display_name":"Olaf van Tellingen","orcid":"https://orcid.org/0000-0002-1037-6269","observed_orcids":["https://orcid.org/0000-0002-1037-6269"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olaf van Tellingen","raw_affiliation_strings":["Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Tel: (+ 31) 20 5122792"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Tel: (+ 31) 20 5122792","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113557752","display_name":"Willem J. Nooijen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Willem J Nooijen","raw_affiliation_strings":["Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Tel: (+ 31) 20 5122792"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Tel: (+ 31) 20 5122792","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jos H Beijnen","raw_affiliation_strings":["Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Tel: (+ 31) 20 5122792"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Tel: (+ 31) 20 5122792","institution_ids":["https://openalex.org/I2898336195"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2898336195"],"apc_list":null,"apc_paid":null,"fwci":2.2165,"has_fulltext":false,"cited_by_count":140,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88354706,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"7","issue":"1","first_page":"78","last_page":"86"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9390000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9390000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.03370000049471855,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8830000162124634},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.859000027179718},{"id":"https://openalex.org/keywords/excretion","display_name":"excretion","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cremophor-el","display_name":"Cremophor EL","score":0.8999999761581421},{"id":"https://openalex.org/keywords/nonlinear-pharmacokinetics","display_name":"nonlinear pharmacokinetics","score":0.7919999957084656},{"id":"https://openalex.org/keywords/biliary-excretion","display_name":"biliary excretion","score":0.7319999933242798},{"id":"https://openalex.org/keywords/detoxification","display_name":"detoxification","score":0.6629999876022339},{"id":"https://openalex.org/keywords/fvb-mice","display_name":"FVB mice","score":0.7329999804496765},{"id":"https://openalex.org/keywords/hplc-determination","display_name":"HPLC determination","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C10146269","wikidata":"https://www.wikidata.org/wiki/Q185557","display_name":"Excretion","level":2,"score":0.7339107990264893},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7130123972892761},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.5763587355613708},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.5123125314712524},{"id":"https://openalex.org/C3019775314","wikidata":"https://www.wikidata.org/wiki/Q1781748","display_name":"Tissue distribution","level":2,"score":0.4754899740219116},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40591734647750854},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37735265493392944},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37592124938964844},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.3714732527732849},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29024460911750793},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.09085044264793396},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0788756012916565},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-199601000-00009","doi":"https://doi.org/10.1097/00001813-199601000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199601000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:8742102","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8742102","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2412887782","https://openalex.org/W2374863283","https://openalex.org/W2066522045","https://openalex.org/W1856793902","https://openalex.org/W1946451131","https://openalex.org/W2032960281","https://openalex.org/W2352254691","https://openalex.org/W4317503097","https://openalex.org/W2376700368"],"abstract_inverted_index":{"So":[0],"far,":[1],"all":[2,189],"animal":[3],"pharmacokinetic":[4,102,109],"studies":[5,110,132],"of":[6,30,38,54,72,90,118,170,186,251,258,285,336,347],"paclitaxel,":[7],"which":[8,225],"used":[9],"analytical":[10],"procedures":[11],"based":[12,66],"on":[13,67],"HPLC,":[14],"have":[15,94],"not":[16,227,300,312],"been":[17],"sensitive":[18,64],"enough":[19],"to":[20,176,188,247,275],"quantify":[21],"drug":[22,36,123,147,200],"levels":[23,37,148,201],"below":[24],"500":[25],"ng/ml.":[26],"Consequently,":[27],"the":[28,31,52,70,75,122,182,184,193,214,217,234,248,261,270,278,293,302,323,330,337],"interpretation":[29],"results":[32],"is":[33,124,239],"restricted":[34],"because":[35],"paclitaxel":[39,73,187,259],"as":[40,42,164],"low":[41],"at":[43,269,277],"least":[44],"50":[45],"nM":[46],"(43":[47],"ng/ml)":[48],"are":[49,318],"relevant":[50],"for":[51,69,181,333],"pharmacology":[53],"this":[55,97,242],"drug.":[56],"We":[57,93],"recently":[58],"described":[59],"an":[60,344],"accurate":[61],"and":[62,74,82,151,158,173,198,288,296,316,325],"very":[63],"method":[65],"HPLC":[68],"determination":[71],"metabolites":[76,286],"3'-p-hydroxypaclitaxel":[77],"(I),":[78],"6":[79,83],"alpha-hydroxypaclitaxel":[80],"(II)":[81],"alpha,3'-p-dihydroxypaclitaxel":[84],"(III)":[85],"in":[86,99,104,111,137,149,155,192,213,221,233,260,292,301,329],"a":[87,100,114,165,230],"wide":[88],"variety":[89],"biological":[91],"matrices.":[92],"now":[95],"implemented":[96],"methodology":[98],"comprehensive":[101],"study":[103],"female":[105,177,194],"FVB":[106,178],"mice.":[107,179],"Previous":[108],"humans":[112],"demonstrated":[113],"large":[115],"steady-state":[116],"volume":[117],"distribution,":[119],"indicating":[120],"that":[121,241],"widely":[125],"distributed":[126],"into":[127,141,322],"tissues.":[128],"Comprehensive":[129],"tissue":[130,235],"distribution":[131,185],"may,":[133],"therefore,":[134],"be":[135,245],"helpful":[136],"providing":[138],"more":[139],"insight":[140],"possible":[142],"relationships":[143],"between":[144],"plasma":[145,222],"levels,":[146],"tissues":[150,191],"toxicity.":[152],"Paclitaxel,":[153],"formulated":[154],"Cremophor":[156,252],"EL":[157,253],"ethanol":[159],"(1:1,":[160],"v/v),":[161],"was":[162,196,223,226,265,311],"given":[163],"single":[166],"i.v.":[167],"bolus":[168],"dose":[169,273,281],"2,":[171],"10":[172],"20":[174,279],"mg/kg":[175,272,280],"Except":[180],"brain,":[183],"other":[190,307],"mice":[195],"substantial":[197,249],"maximum":[199],"were":[202,290],"achieved":[203],"within":[204],"0.5":[205],"or":[206,305],"1":[207],"h.":[208],"A":[209],"marked":[210],"non-linear":[211],"increase":[212,232],"area":[215],"under":[216],"concentration-time":[218],"curve":[219],"(AUC)":[220],"observed,":[224],"paralleled":[228],"by":[229],"proportional":[231],"AUC":[236],"levels.":[237],"It":[238],"postulated":[240],"effect":[243],"may":[244],"related":[246],"amounts":[250,284],"administered":[254,338],"concurrently.":[255],"The":[256],"recovery":[257,328],"feces":[262,331],"(0-96":[263],"h)":[264],"reduced":[266],"from":[267],"58%":[268],"2":[271],"level":[274],"44%":[276],"level.":[282],"Small":[283],"I":[287,315],"II":[289,317],"detected":[291],"gut,":[294],"liver":[295],"gall":[297],"bladder,":[298],"but":[299],"systemic":[303],"circulation":[304],"any":[306],"tissue.":[308],"Metabolite":[309],"III":[310],"detected.":[313],"Metabolites":[314],"likely":[319],"excreted":[320],"directly":[321],"bile,":[324],"since":[326],"their":[327,340],"accounts":[332],"about":[334],"25%":[335],"dose,":[339],"formation":[341],"thus":[342],"represents":[343],"important":[345],"pathway":[346],"detoxification.":[348]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2037469650","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
